Tyra Biosciences Announces Late Oral Presentation of Preliminary Safety and Antitumor Activity of TYRA-300 from SURF301 at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapy (ENA 2024)

October 11, 2024 - by admin - Leave a Comment

Tyra Biosciences Announces Late Oral Presentation of Preliminary Safety and Antitumor Activity of TYRA-300 from SURF301 at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapy (ENA 2024)Yahoo Finance

About admin

View all posts by admin →

Related Posts

Government Shutdown Live Updates: Johnson Says Republicans Agree on New Deal; Democrats still need approval – The Independent

Car crashes into crowd at Christmas market in Germany: Police – ABC13 Houston

L&NW’s Top 10 Stories of 2024 – Label & Narrow Web

About admin

Leave a Reply Cancel reply